The Effects of Fractional CO2 Laser on Poikiloderma of Civatte

Poikiloderma of Civatte Clinical Trial

Official title: The Effects of Fractional CO2 Laser on Poikiloderma of Civatte

Status Completed

Clinical Trial Summary

This study will assess the safety and efficacy of fractional CO2 laser treatment for Poikiloderma of Civatte (POC).POC is a chronic vascular and pigmentary disorder typically involving the lateral and inferior neck region, as well as the chest area. Clinically, poikiloderma appears as a combination of telangiectasia, irregular pigmentation, and atrophic changes.Little data exist regarding the use of fractional CO2 laser for management of POC. This study hopes to fulfill this purpose. The primary outcome will be a blinded assessment by dermatologists in the improvement in POC using the Physician's Global Aesthetic Improvement Scale following therapy. The secondary outcomes include subject satisfaction post-treatment and assessment of all procedure-related adverse events.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Poikiloderma of Civatte

• NCT number: NCT04581330
• Study type: Interventional
• Source: University of Texas Southwestern Medical Center
• Status: Completed
• Phase: N/A
• Start date: April 1, 2021
• Completion date: January 1, 2022